Glaukos (NYSE:GKOS) shares were down this morning on second-quarter results that missed the consensus earnings forecast. The Aliso Viejo, California–based glaucoma treatment developer posted losses of $45.5 million, or 96¢ per share, on sales of $72.7 million for the three months ended June 30, 2022, for a bottom-line slide deeper into the red on a […]
Wall Street Beat
Enovis more than doubles earnings in Q2, scales back EPS guidance
Enovis (NYSE: ENOV) today reported Q2 results that beat The Street on earnings but missed on revenue, with the ortho device company joining the host of medtech companies scaling back earnings projections for the year amid macroeconomic headwinds. Wilmington, Delaware–based Enovis — the parent company of DJO — earned $121 million, or $2.21 per diluted […]
Surgalign settles with SEC for $2M over alleged misreported revenue numbers
Surgalign (Nasdaq:SRGA) announced that it reached a settlement with the U.S. Securities and Exchange Commission (SEC). The settlement concludes and resolves in its entirety an SEC investigation related to activities including pulling sales forward from future quarters to address projected quarterly revenue shortfalls. Activities evaluated in the investigation occurred between 2015 and 2019, back when […]
BD beats The Street in Q3, raises guidance
BD (NYSE: BDX) today announced third-quarter results that beat the consensus forecast on Wall Street and raised both its revenue and EPS guidance, even as management acknowledged a challenging macroeconomic environment. The Franklin Lakes, N.J.–based medtech giant earned $360 million, or $1.28 per share, off $4.64 billion in sales for the quarter ended June 30, […]
Tandem sinks on Q2 misses, slashed sales guidance
Tandem Diabetes Care (Nasdaq:TNDM) shares took a bit hit after hours on second-quarter results that missed the consensus forecast. Shares of TNDM were down 7.2% at $64 per share after the market closed, which was when it released its quarterly results. The San Diego-based automated insulin delivery technology developer posted losses of $15.1 million, or 24¢ […]
Siemens Healthineers sales down nearly 6% in Q3, but it sticks with outlook
Siemens Healthineers (ETR:SHL) shares are on the decline today upon the release of the company’s third-quarter financial results. Shares of SHL were down 0.9% at $24.93 per share in mid-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1%. The company said in […]
AtriCure dips on mixed bag Q2
AtriCure (Nasdaq:ATRC) shares took a slight hit today on second-quarter results that were mixed compared to the consensus forecast. The Mason, Ohio-based cardiac ablation device company posted losses of $14.8 million, or 32¢ per share, on sales of $84.5 million for the three months ended June 30, 2022, for a slight bottom-line gain on sales […]
Owens & Minor shares down on revised outlook
Owens & Minor (NYSE:OMI) today posted Q2 results that matched the overall consensus on Wall Street, though it revised its outlook amid macroeconomic headwinds. The Richmond, Virginia–based healthcare products and services giant reported profits of $28.6 million, or 37¢ per share, on sales of $2.5 billion for the three months ended June 30 for a […]
Inspire Medical Systems revenue up 71% in Q2
Inspire Medical Systems (NYSE: INSP) easily blew past Wall Street predictions in Q2, though the company is scaling back its gross margin projections. Minneapolis-based Inspire Medical is the maker of a minimally-invasive, implantable, pacemaker-like device that uses neurostimulation to treat obstructive sleep apnea. It announced yesterday evening that it lost $14.5 million, or 53¢ per […]
SeaSpine posts mixed-bag Q2 results, raises guidance for fiscal 2022
SeaSpine (NSDQ:SPNE) posted second-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Carlsbad, California–based spine treatment tech company reported losses of $13.9 million, or -38¢ per share, on sales of $56.3 million for the three months ended June 30, 2022, nearly triple the losses versus the same quarter a […]
Butterfly Network rises on Q2 results, will reduce workforce to extend cash runway
Butterfly Network (NYSE:BFLY) shares are up on second-quarter results that beat the consensus forecast, with the company announcing plans to reduce a tenth of its workforce. Shares of BFLY were up more than 16% at $5.66 apiece by the close of trading today. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest […]
